Back to Schonfeld Strategic Advisors LLC Schonfeld Strategic Advisors LLC

KNSAKNSA
Showing 8 of 9 quarters

Position history for Schonfeld Strategic Advisors LLCSchonfeld Strategic Advisors LLC's holdings in KINIKSA PHARMACEUTICALS INTL

Schonfeld Strategic Advisors LLC previously held 0 shares of KNSA (KINIKSA PHARMACEUTICALS INTL), worth $0 as of 2026-Q2.

Final Value

$0

Final Shares

0

Total Value Change

-$2.2M

Total Shares Change

-89,300

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Exited
0
-100.0%
$00.0%$63.95
0
2026-Q1
Decreased
43,599
-31.9%
$2.1M0.0%$45.37
0
2025-Q4
Decreased
63,995
-23.7%
$2.6M0.0%$40.99
0
2025-Q3
Increased
83,881
+22.0%
$3.3M0.0%$38.77
32
2025-Q2
Increased
68,751
+37.9%
$1.9M0.0%$28.04
34
2025-Q1
Increased
49,847
+75.5%
$1.1M0.0%$23.09
38
2024-Q4
Decreased
28,400
-68.2%
$561,7520.0%$19.60
0
2024-Q3
Increased
89,300
+1.0%
$2.2M0.0%$25.00
26

Other major holders of KNSA: FMR LLC, BAKER BROS. ADVISORS LP, BlackRock, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used